Related Experiment Videos
Feline hepatic lipidosis
1Willamette Veterinary Referral Center, Corvallis, OR 97333, USA.
Summary
Feline hepatic lipidosis, or fatty liver disease, occurs when excess fat accumulates in the liver due to starvation. Aggressive nutritional support via tube feeding offers a high survival rate for affected cats.
Area of Science:
- Veterinary Medicine
- Hepatology
- Feline Internal Medicine
Background:
- Hepatic lipidosis (fatty liver disease) in cats results from an imbalance between lipid mobilization to the liver and lipid removal via very-low-density lipoprotein (VLDL) formation or oxidation.
- This condition is frequently linked to overt liver dysfunction and is commonly triggered by starvation in adult cats.
- Impaired removal of hepatic lipids can stem from protein malnutrition, carnitine deficiency, or oxidative damage to hepatic organelles like peroxisomes.
Purpose of the Study:
- To elucidate the pathophysiology of hepatic lipidosis in cats.
- To outline diagnostic criteria for feline hepatic lipidosis.
- To establish the efficacy of aggressive nutritional support as a primary treatment modality.
Main Methods:
- Diagnosis involves a comprehensive evaluation of laboratory results and diagnostic imaging.
- Liver biopsy is a key diagnostic procedure for confirming feline hepatic lipidosis.
- Treatment focuses on aggressive nutritional support, primarily through tube feeding.
Main Results:
- Clinical signs of hepatic lipidosis in cats include weight loss, depression, vomiting, and icterus.
- Aggressive tube feeding as a treatment strategy demonstrates significant efficacy.
- Survival rates following aggressive tube feeding range from 60% to 80%.
Conclusions:
- Hepatic lipidosis is a serious condition in cats, often precipitated by starvation and characterized by impaired lipid metabolism.
- A combination of diagnostic data and liver biopsy is crucial for accurate diagnosis.
- Prompt and aggressive nutritional intervention, particularly tube feeding, is the recommended treatment, leading to favorable survival outcomes.